OPTIMIzation of Treatment SElection and Follow up in Oligometastatic Colorectal Cancer
A study investigating if analysis of circulating tumor DNA (ctDNA) can guide adjuvant treatment in patients with advanced colorectal cancer (CRC)
Trial Details
- NCT ID
- NCT04680260
- Phase
- PHASE2
- Sponsor
- Karen-Lise Garm Spindler
- Status
- RECRUITING
- Cancer Type
- Colon Cancer Colorectal Cancer
- Interventions
- Standard of care
- Circulating tumor DNA guided treatment approach
- Locations (sample)
- Aarhus N, Denmark|56.20367,10.17317
- Vejle, Denmark|55.70927,9.5357
Key Eligibility Criteria
- Radical intended treatment for metastatic spread from CRC, by resection, radiofrequency ablation, stereotactic body radiation therapy (or other exp…
- No evidence of further disease based on pre-treatment work-up according to SOC
- Age at least 18 years
- Eastern Cooperative Oncology Group performance status 0-2
For full eligibility, visit ClinicalTrials.gov.